37735974|t|NRF1 mitigates motor dysfunction and dopamine neuron degeneration in mice with Parkinson's disease by promoting GLRX m6 A methylation through upregulation of METTL3 transcription.
37735974|a|OBJECTIVE: The feature of Parkinson's disease (PD) is the heavy dopaminergic neuron loss of substantia nigra pars compacta (SNpc), while glutaredoxin (GLRX) has been discovered to modulate the death of dopaminergic neurons. In this context, this study was implemented to uncover the impact of GRX1 on motor dysfunction and dopamine neuron degeneration in PD mice and its potential mechanism. METHODS: A PD mouse model was established via injection with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) into mice. After gain- and loss-of-function assays in mice, motor coordination was assessed using rotarod, pole, and open-field tests, and neurodegeneration in mouse SNpc tissues was determined using immunohistochemistry of tyrosine hydroxylase and Nissl staining. NRF1, methyltransferase-like 3 (METTL3), and GLRX expression in SNpc tissues were evaluated using qRT-PCR, Western blot, and immunohistochemistry. The N6-methyladenosine (m6 A) levels of GLRX mRNA were examined using MeRIP. The relationship among NRF1, METTL3, and GLRX was determined by RIP, ChIP, and dual luciferase assays. RESULTS: Low GLRX, METTL3, and NRF1 expression were observed in MPTP-induced mice, accompanied by decreased m6 A modification level of GLRX mRNA. GLRX overexpression alleviated motor dysfunction and dopamine neuron degeneration in MPTP-induced mice. METTL3 promoted m6 A modification and IGF2BP2-dependent stability of GLRX mRNA, and NRF1 increased METTL3 expression by binding to METTL3 promoter. NRF1 overexpression increased m6 A modification of GLRX mRNA and repressed motor dysfunction and dopamine neuron degeneration in MPTP-induced mice, which was counteracted by METTL3 knockdown. CONCLUSION: Conclusively, NRF1 constrained motor dysfunction and dopamine neuron degeneration in MPTP-induced PD mice by activating the METTL3/GLRX axis.
37735974	0	4	NRF1	Gene	18181
37735974	15	32	motor dysfunction	Disease	MESH:D000068079
37735974	37	65	dopamine neuron degeneration	Disease	MESH:D009410
37735974	79	98	Parkinson's disease	Disease	MESH:D010300
37735974	158	164	METTL3	Gene	56335
37735974	206	225	Parkinson's disease	Disease	MESH:D010300
37735974	227	229	PD	Disease	MESH:D010300
37735974	317	329	glutaredoxin	Gene	93692
37735974	331	335	GLRX	Gene	93692
37735974	473	477	GRX1	Gene	93692
37735974	481	498	motor dysfunction	Disease	MESH:D000068079
37735974	503	531	dopamine neuron degeneration	Disease	MESH:D009410
37735974	535	537	PD	Disease	MESH:D010300
37735974	583	585	PD	Disease	MESH:D010300
37735974	633	677	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine	Chemical	MESH:D015632
37735974	679	683	MPTP	Chemical	MESH:D015632
37735974	824	841	neurodegeneration	Disease	MESH:D019636
37735974	909	929	tyrosine hydroxylase	Gene	21823
37735974	950	954	NRF1	Gene	18181
37735974	956	980	methyltransferase-like 3	Gene	56335
37735974	982	988	METTL3	Gene	56335
37735974	995	999	GLRX	Gene	93692
37735974	1101	1119	N6-methyladenosine	Chemical	MESH:C010223
37735974	1121	1125	m6 A	Chemical	MESH:C005955
37735974	1137	1141	GLRX	Gene	93692
37735974	1197	1201	NRF1	Gene	18181
37735974	1203	1209	METTL3	Gene	56335
37735974	1215	1219	GLRX	Gene	93692
37735974	1290	1294	GLRX	Gene	93692
37735974	1296	1302	METTL3	Gene	56335
37735974	1308	1312	NRF1	Gene	18181
37735974	1341	1345	MPTP	Chemical	MESH:D015632
37735974	1385	1389	m6 A	Chemical	MESH:C005955
37735974	1412	1416	GLRX	Gene	93692
37735974	1423	1427	GLRX	Gene	93692
37735974	1454	1471	motor dysfunction	Disease	MESH:D000068079
37735974	1476	1504	dopamine neuron degeneration	Chemical	-
37735974	1508	1512	MPTP	Chemical	MESH:D015632
37735974	1527	1533	METTL3	Gene	56335
37735974	1543	1547	m6 A	Chemical	MESH:C005955
37735974	1565	1572	IGF2BP2	Gene	319765
37735974	1596	1600	GLRX	Gene	93692
37735974	1611	1615	NRF1	Gene	18181
37735974	1626	1632	METTL3	Gene	56335
37735974	1658	1664	METTL3	Gene	56335
37735974	1675	1679	NRF1	Gene	18181
37735974	1705	1709	m6 A	Chemical	MESH:C005955
37735974	1726	1730	GLRX	Gene	93692
37735974	1750	1767	motor dysfunction	Disease	MESH:D000068079
37735974	1772	1800	dopamine neuron degeneration	Disease	MESH:D009410
37735974	1804	1808	MPTP	Chemical	MESH:D015632
37735974	1849	1855	METTL3	Gene	56335
37735974	1893	1897	NRF1	Gene	18181
37735974	1910	1927	motor dysfunction	Disease	MESH:D000068079
37735974	1932	1960	dopamine neuron degeneration	Chemical	-
37735974	1964	1968	MPTP	Chemical	MESH:D015632
37735974	1977	1979	PD	Disease	MESH:D010300
37735974	2003	2009	METTL3	Gene	56335
37735974	2010	2014	GLRX	Gene	93692
37735974	Positive_Correlation	18181	56335
37735974	Association	MESH:D010300	56335
37735974	Association	MESH:C010223	93692
37735974	Association	MESH:D000068079	56335
37735974	Negative_Correlation	18181	93692
37735974	Association	MESH:D000068079	18181
37735974	Negative_Correlation	MESH:D000068079	93692
37735974	Positive_Correlation	MESH:D015632	MESH:D010300
37735974	Negative_Correlation	MESH:C005955	MESH:D015632
37735974	Negative_Correlation	MESH:D009410	18181
37735974	Negative_Correlation	MESH:D015632	18181
37735974	Association	MESH:D010300	18181
37735974	Association	MESH:D015632	MESH:D000068079
37735974	Association	MESH:D009410	56335
37735974	Negative_Correlation	MESH:D015632	56335
37735974	Association	MESH:C005955	56335
37735974	Positive_Correlation	MESH:C005955	18181
37735974	Association	MESH:D009410	93692
37735974	Negative_Correlation	56335	93692
37735974	Association	MESH:D010300	93692
37735974	Negative_Correlation	MESH:C005955	93692
37735974	Association	319765	56335
37735974	Negative_Correlation	MESH:D015632	93692
37735974	Association	319765	93692

